DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Avastin (Bevacizumab) - News

 
 



News related to Avastin (Bevacizumab) and/or conditions it is approved for

Regeneron's Eylea Works Better vs Avastin and Lucentis in Study
Source: Medscape Ophthalmology Headlines [2014.10.20]
Regeneron Pharmaceuticals said its drug Eylea (aflibercept) for diabetic macular edema produced significantly greater improvement in visual acuity from baseline to 52 weeks compared with Genentech's Avastin (bevacizumab) and Lucentis (ranibizumab).
Reuters Health Information

Avastin Approved for Late-Stage Cervical Cancer
Source: MedicineNet Cervical Cancer Specialty [2014.08.18]
Title: Avastin Approved for Late-Stage Cervical Cancer
Category: Health News
Created: 8/15/2014 12:35:00 PM
Last Editorial Review: 8/18/2014 12:00:00 AM

Avastin May Help Fight Early Breast Cancer
Source: MedicineNet capecitabine Specialty [2012.01.26]
Title: Avastin May Help Fight Early Breast Cancer
Category: Health News
Created: 1/26/2012 11:00:00 AM
Last Editorial Review: 1/26/2012 12:00:00 AM

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014